A61K 39 - Medicinal preparations containing antigens or antibodies

Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
08/2006
08/22/2006	US7094576 Detecting helminth infection using synthetic larval proteins; immunoassay; parasiticides
08/22/2006	US7094556 Diagnosis and treatment of malignant neoplasms
08/22/2006	US7094555 Methods of MHC class II epitope mapping, detection of autoimmune T cells and antigens, and autoimmune treatment
08/22/2006	US7094552 Diagnostic test kits
08/22/2006	US7094550 Diagnosing atherosclerosis in humans; obtain blood, incubate with confining complex, detect signal from bound complex, evaluate for atherosclerosis
08/22/2006	US7094549 mass spectroscopy; medical diagnosis/prognosis; kits
08/22/2006	US7094547 Sperm specific proteins
08/22/2006	US7094419 from an implantable immunomodulation device having an impermeable, yet porous, biocompatible outer shell and an inner lumen of a fibrous scaffolding having an antigen or chemotatic agent sufficient to provoke an immune response
08/22/2006	US7094412 Poxvirus containing formulations and process for preparing stable poxvirus containing compositions
08/22/2006	US7094411 Avirulent, immunogenic flavivirus chimeras
08/22/2006	US7094410 DNA vaccine against proliferating endothelial cells and methods of use thereof
08/22/2006	US7094409 Antigen arrays for treatment of allergic eosinophilic diseases
08/22/2006	US7094408 Immunogenicity using a combination of DNA and vaccinia virus vector vaccines
08/22/2006	US7094407 Self cell-penetrating Tat peptide having a self penetrating signal is bound to a human Type-I collagen C-terminal derived peptide
08/22/2006	US7094406 Enterically transmitted non-A/non-B hepatitis viral agent and characteristic epitopes thereof
08/22/2006	US7094405 Peptides which elicit a high neutralizing antibody titer, cytotoxic T lymphocyte response and T helper cell response in a broad range of MHC type recipients
08/22/2006	US7094404 Method for treating malignancy and autoimmune disorders in humans using tac antibodies
08/22/2006	US7094403 Mycobacterium tuberculosis superoxide dismutase
08/22/2006	US7094402 Polynucleotides (with nucleotide sequence operably linked to an expression control sequence) encoding the human IL-11 receptor and fragments
08/22/2006	US7094396 Method for making cytokine specific antibodies and uses thereof
08/22/2006	US7094391 oral Lime disease vaccination using pure Outer surface protein A specific serum Immunoglobulin A antibodies; immunotherapy
08/17/2006	WO2006086775A2 Methods and compositions for reducing systemic toxicity of vectors
08/17/2006	WO2006086561A2 Neutralizing monoclonal antibodies against severe acute respiratory syndrome-associated coronavirus
08/17/2006	WO2006086361A2 ANTILYMPHOCYTE ANTIBODY INDUCTION BY COMBINATION OF AN SlP RECEPTOR AGONIST/MODULATOR AND OF IMMUNOSUPPRESSIVE DRUGS
08/17/2006	WO2006086288A2 Methods for reducing the symptoms of autoimmunity and inflammation using binding proteins against antigens exposed on dead or dying cells
08/17/2006	WO2006086105A2 Methods and compositions for treating intervertebral disc disorders
08/17/2006	WO2006085961A2 Anti-mcp-1 antibodies, compositions, methods and uses
08/17/2006	WO2006085938A2 Il-13 binding agents
08/17/2006	WO2006085910A2 Endotoxin-free moraxella catarrhalis
08/17/2006	WO2006085822A1 Site-specific immunization in order to establish antibodies with specificity for the e7 oncoprotein of high-risk hpvs
08/17/2006	WO2006085797A1 Hypodermic medicinal agent against human candidosis
08/17/2006	WO2006085583A1 Cell permeable peptide
08/17/2006	WO2006085553A1 Anti-tlr6 antibody and utilization of the same
08/17/2006	WO2006085516A1 Support for protein transfer, protein transfer agent using the support, protein transfer method, cell having protein transferred thereinto and method of producing the same
08/17/2006	WO2006085411A1 Novel adjuvant for evoking immune responce and utilization of the same
08/17/2006	WO2006085088A1 New detoxification method
08/17/2006	WO2006085011A1 Means for obtaining avirulent leishmania promastigotes, promastigotes obtained, and the applications thereof
08/17/2006	WO2006084758A1 Human monoclonal antibody specific for lipopolysaccharides (lps) of the pseudomonas aeruginosa iats o11 serotype
08/17/2006	WO2006084694A2 Use of the mcm8 gene for the preparation of a pharmaceutical composition
08/17/2006	WO2006084467A1 Surface-located streptococcus pneumoniae polypeptides
08/17/2006	WO2006084466A2 Surface-located streptococcus pneumoniae polypeptides
08/17/2006	WO2006084337A1 A molecule and chimeric molecules thereof
08/17/2006	WO2006071280B1 Immunoglobulins comprising predominantly a ga1g1cnacman5glcnac2 glycoform
08/17/2006	WO2006068975A3 Binding proteins specific for human matriptase
08/17/2006	WO2006066599A3 Mas related g protein coupled receptors as drug targets
08/17/2006	WO2006065780A3 Combinations of therapeutic agents for treating cancer
08/17/2006	WO2006063974A3 Il-15 antigen arrays and uses thereof
08/17/2006	WO2006062723A3 Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
08/17/2006	WO2006062637A3 Influenza vaccination
08/17/2006	WO2006056031A8 Use of ferrous ions for increasing the immunoreactivity of immunoglobulin preparations
08/17/2006	WO2006051288A3 Ligands that enhance endogenous compounds
08/17/2006	WO2006050155A3 Cancer therapeutic compositions
08/17/2006	WO2006042173A3 Modulators of hepatocyte growth factor activator
08/17/2006	WO2006039135A3 Irta-4 antibodies and their uses
08/17/2006	WO2006038007A3 Inhibitory analogues to block receptors for microbial pathogenic determinants
08/17/2006	WO2006026331A3 Fiber-modified adenoviral vectors for enhanced transduction of tumor cells
08/17/2006	WO2006016238A3 Capsules containing transfected cells, method for preparing the same and uses thereof for immunization and vaccination
08/17/2006	WO2006013106A3 Vaccine for prevention and treatment of hiv-infection
08/17/2006	WO2006005707A3 Method for preventing and treating alzheimer´s disease
08/17/2006	WO2005106039A8 Ibc-1 (invasive breast cancer-1), a putative oncogene amplified in breast cancer
08/17/2006	WO2005049814A3 Novel atypical pneumonia-causing virus
08/17/2006	WO2005021713A3 Vectors expressing sars immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using
08/17/2006	WO2005003719A3 Decontamination of biological fluids using diphenylpyrilium compounds
08/17/2006	WO2004067553A3 Tolerance-induced targeted antibody production
08/17/2006	WO2003104391A3 Antibacterial targets in alloiococcus otitidis
08/17/2006	WO2003087124A3 Hmgn2 peptides and related melecules that selectively home to tumor blood vessels and tumor cells
08/17/2006	WO2003066831A3 Angiogenesis genes
08/17/2006	US20060185026 Atypical protein kinase c isoforms in disorders of the nervous system and cancer
08/17/2006	US20060183884 Compounds and methods for modulating cell adhesion
08/17/2006	US20060183710 Chlamydia oligosaccharides
08/17/2006	US20060183705 Immunoglobins; antibodies; immunogens; hepatitis b surface antigens
08/17/2006	US20060183699 Immunoglobins; antibodies; immunogens; hepatitis b surface antigens
08/17/2006	US20060183674 Compositions and methods for treating diabetes
08/17/2006	US20060183670 Autoantigen composition
08/17/2006	US20060183169 Interleukin-8 homologous polypeptides and therapeutic uses thereof
08/17/2006	US20060182809 System for transporting active substances in a biological system
08/17/2006	US20060182793 Cpg-packaged liposomes
08/17/2006	US20060182769 purified polypeptide comprising T epitope from a liver-stage specific protein; in vitro diagnosis of malaria by standard detection of the immunological reaction; vaccination against the malaria caused by P. falciparum
08/17/2006	US20060182768 Peptides and DNA encoding the peptides useful for immunizations against Coccidioides spp. infections
08/17/2006	US20060182767 Botulinum neurotoxin formulated with a recombinant serum albumin; eliminating the potential of blood-borne contamination with botulinum based pharmaceuticals
08/17/2006	US20060182766 Stabilized protein compositions for topical administration and methods of making same
08/17/2006	US20060182765 Adjuvant activities of B pentamers of LT-IIa and LT-IIb enterotoxin
08/17/2006	US20060182764 Enhancing the effect of vaccines, particularly hepatitus B vaccines, by the use of ribavirin as an adjuvant; single administration
08/17/2006	US20060182763 CD8 T cell epitopes in HPV 16 E6 and E7 proteins and uses thereof
08/17/2006	US20060182762 Enterovirus, vaccines, medicaments and diagnostic kits
08/17/2006	US20060182761 Methionine salvage pathway in Bacillus
08/17/2006	US20060182759 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
08/17/2006	US20060182758 Novel proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections
08/17/2006	US20060182757 Polynucleotides, expression vectors, host cells, biosynthesis of polypeptides, generating antibody responses
08/17/2006	US20060182756 Groups of Borrelia burgdorferi and Borrelia afzelii that cause Lyme Disease in humans
08/17/2006	US20060182755 Novel composition and methods for the treatment of psoriasis
08/17/2006	US20060182754 Abundant extracellular products and methods for their production and use
08/17/2006	US20060182753 Vaccines
08/17/2006	US20060182752 Tri-block polymers for nanosphere-based drug or gene delivery
08/17/2006	US20060182751 Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
08/17/2006	US20060182750 Process for preparing stable drug conjugates
08/17/2006	US20060182749 Binding protein; reduce transport activity; killing cells; antiproliferation agents; antitumor agents; anticancer agents;
08/17/2006	US20060182748 Method of creating antivenom using Emus
08/17/2006	US20060182747 Treatment of autism
08/17/2006	US20060182746 Binding to monoclonal antibody; antitumor agents

1 ... 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 ... 1823